AGM/EGMJul 2, 2026, 08:02 AM
Bone Biologics Schedules Annual Meeting for August 11, 2026
AI Summary
Bone Biologics Corp. announced its Annual Meeting of Stockholders will take place on August 11, 2026, at its corporate headquarters. Stockholders of record as of June 12, 2026, are invited to vote on the election of four directors, an advisory resolution on executive compensation, and the ratification of Weinberg & Company, P.A. as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Proxy materials were made available to stockholders on or about July 2, 2026.
Key Highlights
- Bone Biologics Corp. will hold its Annual Meeting of Stockholders on August 11, 2026, at 11:00 a.m. ET.
- The meeting will be held at the company's offices in Burlington, MA.
- Stockholders will vote on the election of four directors to the Board.
- An advisory (non-binding) vote on executive officer compensation will be held.
- Stockholders will ratify the appointment of Weinberg & Company, P.A. as the independent registered public accounting firm for 2026.
- The record date for stockholders entitled to vote is June 12, 2026.
- Audit fees for Weinberg & Company were $111,155 in 2025 and $89,108 in 2024.
- Intracoastal Capital LLC beneficially owned 9.9% of outstanding common stock as of June 12, 2026.
Price Impact
More from BBLG